MX2013012205A - Metodo para producir substancias con gas sobresaturado, dispositivo de suministro transdermico de las mismas, y usos de las mismas. - Google Patents

Metodo para producir substancias con gas sobresaturado, dispositivo de suministro transdermico de las mismas, y usos de las mismas.

Info

Publication number
MX2013012205A
MX2013012205A MX2013012205A MX2013012205A MX2013012205A MX 2013012205 A MX2013012205 A MX 2013012205A MX 2013012205 A MX2013012205 A MX 2013012205A MX 2013012205 A MX2013012205 A MX 2013012205A MX 2013012205 A MX2013012205 A MX 2013012205A
Authority
MX
Mexico
Prior art keywords
delivery device
methods
transdermal delivery
delivery devices
producing substances
Prior art date
Application number
MX2013012205A
Other languages
English (en)
Spanish (es)
Inventor
Norbert Kiss
Original Assignee
Invisiderm Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/033060 external-priority patent/WO2012144990A1/en
Application filed by Invisiderm Llc filed Critical Invisiderm Llc
Publication of MX2013012205A publication Critical patent/MX2013012205A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/06—Sprayers or atomisers specially adapted for therapeutic purposes of the injector type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/82—Internal energy supply devices
    • A61M2205/8218—Gas operated
    • A61M2205/8225—Gas operated using incorporated gas cartridges for the driving gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/30—Gas therapy for therapeutic treatment of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2013012205A 2011-04-19 2012-04-19 Metodo para producir substancias con gas sobresaturado, dispositivo de suministro transdermico de las mismas, y usos de las mismas. MX2013012205A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US2011/033060 WO2012144990A1 (en) 2011-04-19 2011-04-19 Method of producing substances with supersaturated gas, transdermal delivery thereof, and uses thereof
US201261591443P 2012-01-27 2012-01-27
PCT/US2012/034316 WO2012145555A2 (en) 2011-04-19 2012-04-19 Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof

Publications (1)

Publication Number Publication Date
MX2013012205A true MX2013012205A (es) 2014-05-28

Family

ID=47042166

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013012205A MX2013012205A (es) 2011-04-19 2012-04-19 Metodo para producir substancias con gas sobresaturado, dispositivo de suministro transdermico de las mismas, y usos de las mismas.

Country Status (13)

Country Link
EP (1) EP2699306A4 (de)
JP (1) JP2014515666A (de)
KR (1) KR20140035378A (de)
CN (1) CN103648576A (de)
AU (1) AU2012245373A1 (de)
BR (1) BR112013027006A2 (de)
CA (1) CA2833851A1 (de)
IL (1) IL228970A0 (de)
MX (1) MX2013012205A (de)
RU (1) RU2013151160A (de)
SG (1) SG194215A1 (de)
WO (1) WO2012145555A2 (de)
ZA (1) ZA201307980B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10130800B2 (en) 2012-01-27 2018-11-20 Invisiderm, Llc Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
CN115154882A (zh) * 2014-03-26 2022-10-11 纳诺麦德皮肤护理公司 物质传送装置及头部
EP3411094A4 (de) * 2016-02-05 2019-11-20 Clover Hill Heal Thealthcare, Inc. Verabreichungsvorrichtung für die nasale behandlung mit kohlendioxid und salz und verfahren, einschliesslich niedriger durchflussraten

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851544A (en) * 1997-12-18 1998-12-22 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic skin or hair care compositions containing fluorocarbons infused with carbon dioxide
WO2001064280A1 (en) * 2000-02-28 2001-09-07 Capnia Incorporated Method and apparatus for transcutaneous infusion of carbon dioxide for local relief of pain and other ailments
US6723077B2 (en) * 2001-09-28 2004-04-20 Hewlett-Packard Development Company, L.P. Cutaneous administration system
DE20221228U1 (de) * 2002-11-12 2005-07-07 Bode, Lothar Druckinjektions-Handgerät zum Einbringen von Substanzen unter Druck eines gasförmigen oder flüssigen Druckmittels in eine zu behandelnde Hautstelle
US7857167B1 (en) * 2005-08-29 2010-12-28 Anthony Scott Hollars Compressed gas cartridge permeation dispenser having a predictable permeation rate
BRPI0604018A (pt) * 2006-08-31 2008-08-26 Mario Augusto Da Silva Freitas método e equipamento que associam a injeção parenteral do dióxido de carbono medicinal (co2) de modo concomitante com a aplicação de radiação infravermelha de fontes térmicas e/ou luminosas utilizando controle por meio de termometria cutánea e/ou corporal
JP5600098B2 (ja) * 2008-04-09 2014-10-01 レスピデルム コーポレイション 薬剤、医療又は精製された炭酸ガスの分散及び経皮的な投与のための可動な装置
BRPI0922416A2 (pt) * 2008-12-26 2015-12-15 Acp Japan Co Ltd sistema de banho de névoa de gás dióxido de carbono sob pressão.
US8118777B2 (en) * 2009-05-29 2012-02-21 Cook Medical Technologies Llc Systems and methods for delivering therapeutic agents
CN102470068A (zh) * 2009-07-14 2012-05-23 艾缪思有限公司 碳酸气经皮吸收装置、碳酸气经皮吸收方法以及包围体

Also Published As

Publication number Publication date
CN103648576A (zh) 2014-03-19
ZA201307980B (en) 2014-06-25
RU2013151160A (ru) 2015-05-27
IL228970A0 (en) 2013-12-31
BR112013027006A2 (pt) 2016-12-27
EP2699306A2 (de) 2014-02-26
AU2012245373A1 (en) 2013-11-14
EP2699306A4 (de) 2016-07-27
WO2012145555A2 (en) 2012-10-26
CA2833851A1 (en) 2012-10-26
JP2014515666A (ja) 2014-07-03
KR20140035378A (ko) 2014-03-21
SG194215A1 (en) 2013-11-29
WO2012145555A3 (en) 2013-01-17

Similar Documents

Publication Publication Date Title
MX2013012206A (es) Metodo para producir substancias con gas sobresaturado,dispositivo de suministro transdermico de las mismas, y usos de las mismas.
MX362626B (es) Métodos para tratar pacientes pediátricos usando dexmedetomidina..
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
WO2008131057A3 (en) Sustained release formulations of opioid and nonopioid analgesics
WO2011163594A3 (en) Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
MY168791A (en) Carbamate compounds and of making and using same
UA115139C2 (uk) Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
WO2011112229A3 (en) Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
MX365688B (es) Sistemas de administracion de farmaco y metodos para el tratamiento del cancer de vejiga que comprenden oxaliplatino.
MX367070B (es) Sistemas de administracion de farmaco y metodos para el tratamiento de la prostata.
CO7101247A2 (es) Formulaciones de ácido poliinosínico-policitidílico (poli(i:c)) para el tratamiento de infecciones de las vías respiratorias altas
MX335951B (es) Agente terapeutico/profilactico que contiene pth para la osteoporosis, caracterizado porque la pth se administra una vez a la semana en una dosis unitaria de 100 a 200 unidades.
WO2008025790A3 (en) Use of opioid formulations in needle-less drug delivery devices
MX2020001768A (es) Metodos de tratamiento de la osteoartritis con gel de canabidiol transdermico.
WO2014072423A3 (en) Agitation apparatus
EP3970729A3 (de) Verfahren zur verabreichung hoher konzentrationen von stickoxid
WO2016100949A3 (en) Method and compositions for dissolving or solubilizing therapeutic agents
MX2013012204A (es) Metodo para producir substancias con gas sobresaturado, dispositivo de suministro transdermico de las mismas, y usos de las mismas.
WO2008051527A3 (en) Sustained release of agents for localized pain management
MX2013012205A (es) Metodo para producir substancias con gas sobresaturado, dispositivo de suministro transdermico de las mismas, y usos de las mismas.
MX341660B (es) Agonista del receptor de ghrelina para el tratamiento de caquexia.
EA201591415A1 (ru) Фармацевтические композиции, включающие многокомпонентные кристаллические частицы, подходящие для применения в ингаляционной терапии
NZ754328A (en) Marker for acid sphingomyelinase disorders and uses thereof
AR086491A1 (es) Composicion farmaceutica que comprende fexofenadina

Legal Events

Date Code Title Description
FA Abandonment or withdrawal